venBio Partners LLC

venBio Partners LLC reported 9 holdings worth US$496M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

venBio Partners LLC reported 9 holdings worth US$496M as of Sep 30, 2026. Largest: Parabilis Medicines, Inc., Attovia Therapeutics, Inc. and Achieve Life Sciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
9
Value as reported
US$496M

The filing in full

CompanySharesValue as reported% of portfolio
Parabilis Medicines, Inc.5.27MUS$170M34.3%
Attovia Therapeutics, Inc.4.18MUS$71.7M14.5%
Achieve Life Sciences, Inc.5.91MUS$47.9M9.6%
Alumis Inc.4.19MUS$31M6.2%
ALX Oncology Holdings Inc.12.9MUS$17.9M3.6%
Lyell Immunopharma, Inc.338KUS$3.31M0.67%
Lisata Therapeutics, Inc.156KUS$225K0.05%
Harmony Biosciences Holdings, Inc.0US$00.00%

Source

Download original · View original at SEC

Related